Ozempic Maker Is Ready to Fight Back Against Hims & Hers

Shares of Hims & Hers Health (HIMS) are getting crushed today after the Food & Drug Administration determined there is no longer a shortage...

3 Pharma Stocks Getting Fat Off GLP-1: Here's the Best Buy Now

Next to artificial intelligence, one of the biggest investment themes over the past few years has been a class of anti-obesity drugs called...

Eli Lilly Faces ‘Death Cross’ Selloff: This is the Stock's Next Target Price...

Shares of Eli Lilly (LLY) and other pharmaceutical companies dropped significantly on Friday.  The selloff was triggered by the announcement that...

Novo Nordisk Faces 20-Year Worst Stock Drop: Bear Market Price Target Revealed

Novo Nordisk (NVO) stock dropped more than 15% on Friday following an update on its obesity drug that fell short of expectations. Headlines from the...

Pages 1 of 1